Intuniv XR · DIN 02409119 · 2 mg · extended release tablet
Limited Use, Reason for Use code 540 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 540 required
Write on scriptReason for Use code 540 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 540
Reason for Use code 540
For the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 to 17 years who meet the following criteria:
(i) As adjunctive therapy to psychostimulants; OR
(ii) As monotherapy in patients who have significant intolerance to psychostimulants AND who have had an inadequate response to either atomoxetine or other non-stimulant alternative(s).
Coverage limit:
LU Authorization Period: 1 year
Savings card: innoviCares lists Intuniv XR (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Intuniv XR · DIN 02409119
Manufacturer: Takeda Canada Inc.; listing date 2020-01-31
Health Canada: Marketed since 2021-07-29 · brand INTUNIV XR · ATC C02AC02 GUANFACINE · form Tablet (extended-release) · route Oral · ingredients GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG · company Takeda canada inc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02409119)
Source record
DIN 02409119: Intuniv XR
Raw flags: sec12=Y, sec3=Y
Item: 240816002; group id 360; item number 0841; lccId 00326; manufacturer id TAK
Source form: ER Tab; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.7413; ministry $0.9353
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02409119
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89384
Interchangeable products
Apo-Guanfacine XR · DIN 02523736 · $0.9353
Jamp Guanfacine XR · DIN 02523566 · $0.9353
Sandoz Guanfacine XR · DIN 02563193 · $0.9353
Shortage status: not checked (no credentials)